The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Catalent has agreed to acquire Paragon Bioservices, a Baltimore, Maryland-based contract provider of viral vector development and manufacturing services for gene therapies, for $1.2 billion.
Paragon has specialized expertise in adeno-associated...
The latest news from CDMOs, CMOS, and other suppliers featuring news from Wilmington PharmaTech, Insilico, ACG Group, Lonza
Chemicals/Chemical API Manufacturing
Wilmington PharmaTech To Invest $18 Million In New Research and Mfg Facility...
GE has entered into a definitive agreement to sell its BioPharma business to Danaher Corporation, a global science and technology company, headquartered in Washington D.C., for a total consideration of $21.4 billion, including $21 billion in cash...
The latest news from CDMOs, CMOS, and other suppliers featuring news from Charkit, Thermo Fisher Scientific Pharma Services, MilliporeSigma, Charles Rivers, Ompi, and LabVantage.
Chemicals/Chemical API Manufacturing
Charkit Chemical Names New...
The latest news from contract development and manufacturing organizations, contract manufacturing organizations, and other suppliers featuring news from Cerbios-Pharma, Olon, Hovione, Thermo Fisher, GE Healthcare Life Sciences, and PCI Pharma...
Hitachi Chemical, a Tokyo-based chemicals and industrial manufacturer, has agreed to acquire Apceth Biopharma, a Munich, Germany-based contract development and manufacturing organization (CDMO) of cell and gene therapies, for EUR 75.5 million...
A roundup of news from suppliers, contract development and manufacturing organizations (CDMOs), and contract manufacturing organizations (CMOs), featuring developments from Almac, Pii, PCI Pharma Services, MedPharm, and Thousand Oaks...
Boehringer Ingelheim has initiated a capacity expansion in its biopharmaceutical contract manufacturing business at its commercial manufacturing site for biologics in China. The expansion covers an additional bioreactor and includes all needed...
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) of biologics and part of Fujifilm Corporation, plans to invest approximately JPY 10 billion (approximately $90 million) to expand existing production...
Catalent has announced an investment of $200 million in its biologics business to expand drug-substance manufacturing capacity and drug-product fill/finish capacity. The investments, phased over a three-year program, will be undertaken at the...
AGC Biologics, a contract manufacturer of biologics, has finalized plans to install 12 additional 2,000-liter single-use mammalian cell bioreactors and to establish a brand-new microbial contract development and manufacturing facility at its site...
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients and drug products, has completed its previously announced acquisition of Avista Pharma Solutions, a Durham, North Carolina-headquartered contract testing,...
A roundup of news from suppliers, contract development and manufacturing organizations, and contract manufacturing organizations, featuring news from Rentschler Biopharma, Pall, Recipharm, 3P Biopharmaceuticals, Fujifilm Irvine Scientific, and...
A roundup of the latest news from suppliers, contract development and manufacturing organizations, and contract manufacturing organizations, featuring Cambrex, WuXi AppTec, Lonza, and Roquette.
Chemicals/Chemical API Manufacturing
Cambrex...
A roundup of the latest news from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring Catalent Pharma Solutions and ABL.
Biologics manufacturing
ABL Expands Viral Vector...
